Event-Driven Stocks

BioNexus Gene Lab Corp

BGLC

Other · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs3 good4 warning1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$7.4M$9.5M$9.8M$10.9M$13.4M$11.4M
Operating income−$3.0M−$1.6M−$2.6M−$291,177$1.1M$1.3M
Net income−$3.0M−$1.6M−$2.6M−$355,966$751,571$1.1M
Total assets$9.3M$10.4M$11.4M$8.7M$9.6M$10.1M
Total liabilities$637,856$2.1M$1.7M$2.1M$2.4M$3.5M
Equity$8.6M$8.3M$9.7M$6.7M$7.2M$6.7M
EPS (diluted)$-0.09$-0.17
Shares out.2.4M18.0M17.7M171.2M171.2M102.7M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−39.9%
Net margin
−40.2%
Return on equity
−34.6%
Return on assets
−32.3%
Return on capital (ROCE)
−34.0%
Liabilities / assets
6.9%
Debt / equity
0.07×
Book value / share
$3.56
Revenue growth (YoY)
−21.9%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
13.26safe
Accruals / assets
12.4%clean
Beneish M-Score
-3.31normal
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
40
/ 100
Profitability 0Growth 0Catalyst 33Earnings quality 67Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

1 severe4 warning3 good
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Revenue declined year-over-year
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202610,5742.2+5.9%
Apr 30, 20269,9822.1+0.1%
Apr 15, 20269,9684.5-58.1%
Mar 31, 202623,8003.7+4.7%
Mar 13, 202622,7373.8-16.6%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.